Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Vaccinogen, Inc. (VGEN) Starts Presentation at 2015 Marcum MicroCap Conference

Vaccinogen is a cancer vaccine company that is clinically testing OncoVAX®, a treatment designed to prevent the recurrence of colon cancer and potentially other solid tumors. The patented process leverages a patient’s own live tumor cells to launch a broad immune response against minimal residual disease. Vaccinogen believes that OncoVAX®, at an optimal dose and regimen, is the first colon cancer vaccine to demonstrate effectiveness in preventing cancer recurrence after surgical resection by addressing the diversity of cancer cells inherent to each patient’s tumor. Five clinical studies of OncoVAX® have been completed to date. Vaccinogen expects to begin enrolling patients in a pivotal phase 3b trial under an FDA Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) when adequate funding is obtained. For more information, visit the company’s website at www.vaccinogeninc.com.

Posted in Marcum MicroCap | Leave a comment

ImmunoVaccine, Inc. (IMMVF) Starts Presentation at 2015 Marcum MicroCap Conference

Immunovaccine develops cancer immunotherapies and infectious disease vaccines based on the company’s DepoVax™ platform, a patented formulation that provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Immunovaccine has advanced two T cell activation therapies for cancer through phase 1 human clinical trials and is currently conducting a phase 2 study with its lead cancer vaccine therapy, DPX-Survivac, in recurrent lymphoma. DPX-Survivac is expected to enter additional phase 2 clinical studies in ovarian cancer and glioblastoma (brain cancer). Immunovaccine is also advancing an infectious disease pipeline including innovative vaccines for respiratory syncytial virus (RSV) and anthrax. For more information, visit the company’s website at  www.imvaccine.com

Posted in Marcum MicroCap | Leave a comment

General Cannabis Corp. (CANN) Starts Presentation at 2015 Marcum MicroCap Conference

Advanced Cannabis Solutions, d/b/a General Cannabis, is a service provider to businesses in the regulated cannabis industry throughout the United States. The company leases commercial real estate and equipment to licensed marijuana business operators for their production needs and provides security services, including armed guards, cash transport and secure cannabis transport services. It also operates The Greenhouse, a shared workspace environment, in Denver, Colorado, while pursuing ancillary business products and services including customized finance, capital formation, banking, regulatory compliance consulting and advanced logistical support for growing operations. For more information, visit the company’s websites at www.generalcann.com and www.advcannabis.com.

Posted in Marcum MicroCap | Leave a comment

Implant Sciences Corp. (IMSC) Starts Presentation at 2015 Marcum MicroCap Conference

Implant Sciences develops and manufactures advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The company’s team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 60 countries worldwide. The company’s ETDs have received approvals and certifications from several international regulatory agencies in the U.S., Europe, China, Russia, France, and Germany. It has also received the GSN Homeland Security Award for “Best Explosives Detection Solution” two years in a row (2013 and 2014).  All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For more information, visit the company’s website at www.implantsciences.com.

Posted in Marcum MicroCap | Leave a comment

Juniper Pharmaceuticals, Inc. (JNP) Starts Presentation at 2015 Marcum MicroCap Conference

Juniper Pharmaceuticals (formerly Columbia Laboratories) is a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in women’s health.  Juniper has a successful heritage in developing pharmaceutical products, including CRINONE® 8% (progesterone gel), which is marketed by Actavis, Inc. in the U.S. and by Merck Serono S.A. in over 60 countries worldwide. The company leverages in-house pharmaceutical development, clinical trial manufacturing and analytical capabilities to advance an internal development pipeline, while also providing valuable consultative services to its pharmaceutical industry customers. For more information, visit the company’s website at: www.juniperpharma.com

Posted in Marcum MicroCap | Leave a comment

Midwest Energy Emissions Corp. (MEEC) Starts Presentation at 2015 Marcum MicroCap Conference

Midwest Energy Emissions delivers patented and proprietary solutions to the global coal-power industry to remove mercury from their power plant emissions, providing performance guarantees and leading edge emissions services. The U.S. Environmental Protection Agency’s (EPA) Mercury and Air Toxic Standards (MATS) rule requires that all coal- and oil-fired power plants in the U.S., larger than 25 mega-watts, must remove roughly 90% of mercury from their emissions starting April 16, 2015. ME2C has developed patented technology and proprietary products that have been shown to achieve mercury removal levels compliant with MATS at a significantly lower cost and with less operational impact than currently used methods, while preserving the marketability of fly-ash for beneficial use. For more information, visit the company’s website at: www.midwestemissions.com

Posted in Marcum MicroCap | Leave a comment

Social Reality, Inc. (SCRI) Starts Presentation at 2015 Marcum MicroCap Conference

Social Reality is an Internet advertising and platform technology company focused on providing tools for the automation of digital advertising market in the United States. SCRI offers display, mobile, video and email advertising inventory to brands and advertising agencies. The company also provides managed advertising services utilizing data from platforms, including Facebook, Yahoo, LinkedIn, and Google to optimize digital advertising for its customers. For more information, visit the company website at www.socialreality.com

Posted in Marcum MicroCap | Leave a comment

Multimedia Platforms, Inc. (MMPW) Starts Presentation at 2015 Marcum MicroCap Conference

Multimedia Platforms is a multimedia technology and publishing company that integrates print media with social media and related online platforms to deliver information and advertising to niche markets. MMP’s proven business model delivers niche publications and online platforms targeting the lesbian, gay, bisexual and transgender population. MMP’s top brands include The Agenda, a Florida-based weekly LGBTQ newspaper covering world, national and local news and events; and Guy Magazine, a weekly entertainment and lifestyle full-color publication covering the burgeoning South Florida LGBTQ marketplace. For more information, visit www.mmpworldwideinc.com

Posted in Marcum MicroCap | Leave a comment

TapImmune, Inc. (TPIV) Starts Presentation at 2015 Marcum MicroCap Conference

TapImmune is an immunotherapy company specializing in the development of innovative technologies for the treatment of cancer and infectious diseases. The company’s peptide or nucleic acid-based immunotherapeutics, comprise one or multiple naturally-processed epitopes designed to comprehensively stimulate a patients’ killer T-cells, helper T-cells and to restore or further augment antigen presentation by using proprietary nucleic acid-based expression systems. The company’s technologies may be used as stand-alone medications or in combination with current treatment modalities. For more information, visit the company’s website at www.tapimmune.com.

Posted in Marcum MicroCap | Leave a comment

Towerstream Corp. (TWER) Starts Presentation at 2015 Marcum MicroCap Conference

Towerstream and its subsidiaries provide various wireless communication services to commercial customers in the United States. It operates through two segments, Fixed Wireless and Shared Wireless Infrastructure. The Fixed Wireless segment offers fixed wireless broadband services and delivers access over a wireless network transmitting over regulated and unregulated radio spectrum. TWER’s wireless broadband service supports bandwidth on demand, wireless redundancy, virtual private networks, disaster recovery, bundled data, and video services. For more information, visit the company’s website at www.towerstream.com

Posted in Marcum MicroCap | Leave a comment